Total submissions: 6
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Gene |
RCV001698316 | SCV000533690 | likely benign | not provided | 2020-10-09 | criteria provided, single submitter | clinical testing | |
Invitae | RCV000873726 | SCV001015779 | likely benign | Heterotopia, periventricular, X-linked dominant; Melnick-Needles syndrome; Oto-palato-digital syndrome, type II; Frontometaphyseal dysplasia | 2023-11-24 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV002451043 | SCV002736837 | likely benign | Familial thoracic aortic aneurysm and aortic dissection | 2022-04-21 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Women's Health and Genetics/Laboratory Corporation of America, |
RCV003987538 | SCV004803575 | likely benign | not specified | 2024-01-22 | criteria provided, single submitter | clinical testing | |
Joint Genome Diagnostic Labs from Nijmegen and Maastricht, |
RCV001698316 | SCV002037500 | likely benign | not provided | no assertion criteria provided | clinical testing | ||
Clinical Genetics DNA and cytogenetics Diagnostics Lab, |
RCV001698316 | SCV002038159 | likely benign | not provided | no assertion criteria provided | clinical testing |